Appraisals - ASAR & FAR

08/08/2019

Final Recommendation: perampanel (Fycompa) 1219

02/08/2019

Final Recommendation: pazopanib (Votrient) 549

31/07/2019

Final Recommendation: pasireotide (Signifor) 643

06/08/2019

Final Recommendation: paliperidone palmitate (Xeplion) 1579

05/09/2019

Final Recommendation: paclitaxel albumin (Abraxane) 232

01/08/2019

Final Recommendation: oseltamivir (Tamiflu) 2800

01/08/2019

Final Recommendation: olodaterol (Striverdi Respimat) 1537

09/08/2019

Final Recommendation: nevirapine (Viramune) 1430

06/08/2019

Final Recommendation: nepafenac (Nevenac) 1509

02/08/2019

Final Recommendation: nepafenac (Nevenac) 1509

19/08/2019

Final Recommendation: midazolam (Buccolam) 1046

27/09/2019

Final Recommendation: methoxypolyethyleneglycol-epoetinbeta (Mircera) 200

27/09/2019

Final Recommendation: mecasermin (Increlex) 196

31/07/2019

Final Recommendation: magnaspartate (Magnaspartate) 2596

01/08/2019

Final Recommendation: macitentan (Opsumit) 711

01/08/2019

Final Recommendation: lurasidone (Latuda) 1142

02/08/2019

Final Recommendation: lixisenatide (Lyxumia) 863

02/08/2019

Final Recommendation: lixisenatide (Lyxumia) 863

02/08/2019

Final Recommendation: lisdexamfetamine dimesylate (Elvanse) 188

01/08/2019

Final Recommendation: lipegfilgrastim (Lonquex) 1297